SOTYKTU (deucravacitinib) is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). It is not known if SOTYKTU is safe and effective in children under 18 years of age.
SORRY, WE CAN’T FIND THAT PAGE!
You may have an outdated link or typed the URL incorrectly. Go to the homepage to find what you are looking for.